AI assistant
EverQuote, Inc. — Director's Dealing 2018
Jun 27, 2018
32354_dirs_2018-06-27_d387de46-943e-4f7c-bbc1-941a7a5b2410.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EverQuote, Inc. (EVER)
CIK: 0001640428
Period of Report: 2018-06-27
Reporting Person: Birnbaum Seth (Director, President and CEO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Class B Common Stock | $ | Class A Common Stock (579104) | Direct | ||
| Stock Option (right to buy) | $6.89 | 2026-01-10 | Class B Common Stock (240224) | Direct | |
| Series A Preferred Stock | $ | Class B Common Stock (1064520) | Indirect |
Footnotes
F1: The Class B Common Stock is convertible into the issuer's Class A Common Stock on a one-for-one basis upon certain transfers of such shares and at the holder's election. The Class B Common Stock has no expiration date.
F2: This option to purchase up to an aggregate total of 320,000 shares of Class B Common Stock was granted on January 11, 2016. The shares underlying the option are scheduled to vest over six years in seventy-two equal monthly installments with the first installment vested on December 31, 2015.
F3: The Series A Preferred Stock is convertible into the issuer's Class B Common Stock on a one-for-eight basis into the number of shares of Class B Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the issuer's initial public offering of its Class A Common Stock pursuant to a registration statement on Form S-1 (File No. 333-225379) under the Securities Act of 1933, as amended. The shares have no expiration date.
F4: Consists of shares held by Cogo Labs, Inc., with respect to which Cogo Labs, Inc. has empowered Mr. Birnbaum and Mira Wilczek, acting together and not individually, to exercise investment power, which may be revoked by Cogo Labs, Inc. at any time. Mr. Birnbaum disclaims beneficial ownership of the shares owned directly by Cogo Labs, Inc. except to the extent of any pecuniary interest therein.